The following jobs are currently available. Kindly refer to the individual advertisements below and apply directly if you are interested in the respective positions. Good luck!
Mylan Laboratories Inc. will acquire Merck's generics business ("Merck Generics") for €4.9 billion ($6.7 billion). This marks another consolidation of the generic industry.
The combination of Mylan and Merck Generics will diversify their product portfolio and broaden their global footprint.
In the recent Annual Meeting of APhA in Atlanta, American pharmacists gathered to explore new challenges and advances in pharmacy, including sessions to reduce medication errors.
Among the more than 80 programs presented were several sessions that dealt with reducing medication errors and adverse events, a topic that has received widespread media attention.
Starting May 26th, NUS Department of Pharmacy is partnering with Department of Chemistry to organize a Traditional Chinese Medicine (TCM)
This is part of the main exhibition on China:7000 years of Innovation. Many of our Pharmacy faculty members are offering exhibits so please visit our exhibit and show your support!
Event: China:7000 years of Innovation
The US and European regulatory watchdogs for drug safety have issued safety advisory to both healthcare professionals and public about the risks of GSK’s Avandia (rosiglitazone).
Issued on May 21 and May 23 respectively, the press release press releases by these 2 influential agencies drew reference to the recently published article in NEJM.
An unusually harsh sentence was meted out recently to the ex-commissioner of Chinese food and drug regulatory agency for taking bribes and dereliction of duty.
When we are asked about the “super drug” of our times, not too many quite come through our mind as impressively as a humble agent called aspirin.
To me personally, aspirin is one with such profound appeals and ability to keep authors of many pharmacology textbooks rewriting its new uses and new findings.
